Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer

Annals of Oncology

Volumn 23, Issue 1, 2012, Pages 251-256

  Brandt, A ^a   Sundquist, J ^b,c   Hemminki, K ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Familial prostate cancer; Fatal prostate cancer; Population based study; Prostate

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CLUSTER ANALYSIS; CONTROLLED STUDY; COUNSELING; DISEASE ASSOCIATION; FAMILIAL CANCER; FAMILY HISTORY; FATALITY; FEMALE; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT;

EID: 84855179971     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr056     Document Type: Article

References (26)

1. Brandt A, Bermejo JL, Sundquist J, Hemminki K. Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol 2010; 58: 275-280.
2. Zeegers MP, Jellema A, Ostrer H. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer 2003; 97: 1894-1903.
3. Albright LA, Schwab A, Camp NJ et al. Population-based risk assessment for other cancers in relatives of hereditary prostate cancer (HPC) cases. Prostate 2005; 64: 347-355.
4. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004; 1: e65.
5. Eldon BJ, Jonsson E, Tomasson J et al. Familial risk of prostate cancer in Iceland. BJU Int 2003; 92: 915-919.
6. Pakkanen S, Pukkala E, Kainulainen H et al. Incidence of cancer in Finnish families with clinically aggressive and nonaggressive prostate cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 3049-3056.
7. Hemminki K, Ji J, Forsti A et al. Concordance of survival in family members with prostate cancer. J Clin Oncol 2008; 26: 1705-1709.
8. Tryggvadottir L, Vidarsdottir L, Thorgeirsson T et al. Prostate cancer progression and survival in BRCA2 mutation carriers. J Natl Cancer Inst 2007; 99: 929-935.
9. Watters JL, Park Y, Hollenbeck A et al. Cigarette smoking and prostate cancer in a prospective US cohort study. Cancer Epidemiol Biomarkers Prev 2009; 18: 2427-2435.
10. Hemminki K, Li X, Plna K et al. The nation-wide Swedish Family-Cancer Database: updated structure and familial rates. Acta Oncol 2001; 40: 772-777.
11. Centre for Epidemiology. Cancer Incidence in Sweden 2008. Stockholm, Sweden: National Board of Health and Welfare 2009.
12. Hemminki K, Chen B. Familial association of prostate cancer with other cancers in the Swedish Family-Cancer Database. Prostate 2005; 65: 188-194.
13. Johansson LA, Bjorkenstam C, Westerling R. Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995. J Clin Epidemiol 2009; 62: 1202-1209.
14. Johansson LA, Westerling R. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Int J Epidemiol 2000; 29: 495-502.
15. Hemminki K, Rawal R, Bermejo JL. Prostate cancer screening, changing agespecific incidence trends and implications on familial risk. Int J Cancer 2005; 113: 312-315.
16. Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009; 101: 1325-1329.
17. Bermejo JL, Hemminki K. Familial risk of cancer shortly after diagnosis of the first familial tumor. J Natl Cancer Inst 2005; 97: 1575-1579.
18. Shah M, Zhu K, Palmer RC, Wu H. Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men. Prev Med 2007; 44: 459-464.
19. Vaittinen P, Hemminki K. Familial cancer risks in offspring from discordant parental cancers. Int J Cancer 1999; 81: 12-19.
20. Risbridger GP, Davis ID, Birrell SN, Tilley WD. Breast and prostate cancer: more similar than different. Nat Rev Cancer 2010; 10: 205-212.
21. Gronberg H, Bergh A, Damber JE, Emanuelsson M. Cancer risk in families with hereditary prostate carcinoma. Cancer 2000; 89: 1315-1321.
22. Hemminki K, Forsti A, Lorenzo Bermejo J. Etiologic impact of known cancer susceptibility genes. Mutat Res 2008; 658: 42-54.
23. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
24. West-Wright CN, Henderson KD, Sullivan-Halley J et al. Long-term and recent recreational physical activity and survival after breast cancer: the California Teachers Study. Cancer Epidemiol Biomarkers Prev 2009; 18: 2851-2859.
25. Giovannucci EL, Liu Y, Leitzmann MF et al. A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med 2005; 165: 1005-1010.
26. Weires M, Bermejo JL, Sundquist J, Hemminki K. Clustering of concordant and discordant cancer types in Swedish couples is rare. Eur J Cancer 2011; 47: 98-106.